Global Human Rabies Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431599
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Bio Med Pvt. Ltd.
  • Biological E Ltd.
  • Cadila Healthcare
  • GlaxoSmithKline GmbH
  • Grifols S.A.
  • Kamada Ltd.
  • MORE
Human Rabies Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global Human Rabies Treatment market was valued at US$ 2.71 Bn in 2016, and is expected to reach US$ 4.32 Bn by 2025, expanding at a CAGR of 5.3% from 2017 to 2025.

Market Insights

Rabies is a fatal neurological disease, usually spread to humans through the bite of a rabid animal, and it is a persistent global problem. Some factors such as growing number of preventive vaccines and rising treatment awareness are prime factors that are driving the growth of human rabies treatment market globally. For the purpose of the study global human rabies treatment market is segmented on the basis of product type such as cell culture vaccines, rabies immunoglobulin, nerve tissue vaccines and other. It is estimated that, cell culture vaccines will grow significantly during forecast period due to its safety, higher immunogenicity, fewer adverse effects and negligible allergic reactions compared to other types of human rabies treatment. Based on treatment type, global human rabies treatment market is categorized as pre-exposure immunization and post-exposure prophylaxis and it is observed that, demand for post-exposure prophylaxis is increasing in developing countries because post-exposure prophylaxis is the only safe and effective treatment available in market to prevent exposed persons from acquiring rabies infection. According to World Health Organization (WHO), every year more than 15 million people worldwide receive a post-bite vaccination. Currently demand for the prophylaxis treatment is highest in North America due to developed healthcare infrastructure and high treatment awareness. It is estimated that, Asia-Pacific will show significant market growth during forecast period due to increasing treatment awareness, developing economic condition, populous countries and increasing government initiatives in prevention of rabies.

Market Competition Assessment

The Human Rabies Treatment market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Bio Med Pvt. Ltd., Biological E, Cadila Healthcare, CSC Pharmaceuticals International, GlaxoSmithKline GmbH, Grifols S.A., Kamada Ltd., Kedrion S.p.A., Novartis International AG, Sanofi Pasteur SA, Serum institute of India and other.

Key Market Movements:
  • Factors such as increasing treatment awareness and rising government initiatives in prevention of rabies are prime factors that driving the growth of human rabies treatment market during forecast period.
  • Poor patient compliance to medication and undeveloped healthcare infrastructure in some Asian and African countries where highest number of affected population is located are negatively impacting the market growth of human rabies treatment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bio Med Pvt. Ltd.
  • Biological E Ltd.
  • Cadila Healthcare
  • GlaxoSmithKline GmbH
  • Grifols S.A.
  • Kamada Ltd.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Human Rabies Treatment Market Snapshot
2.2 Global Human Rabies Treatment Market, by Product Type
2.3 Global Human Rabies Treatment Market, by Treatment Type, 2016 (US$ Bn)
2.4 Global Human Rabies Treatment Market Share, by Geography, 2016 (Value %)

Chapter 3 Human Rabies Treatment Market Analysis
3.1 Global Human Rabies Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Human Rabies Treatment Market

Chapter 4 Global Human Rabies Treatment Market, by Product Type
4.1 Overview
4.2 Attractive Investment Proposition: Global Human Rabies Treatment Market, by Product Type
4.3 Top 3 Countries
4.4 Cell Culture Vaccines
4.5 Rabies Immunoglobulin
4.6 Nerve Tissue Vaccines
4.7 Other

Chapter 5 Global Human Rabies Treatment Market, by Treatment Type
5.1 Overview
5.2 Attractive Investment Proposition: Global Human Rabies Treatment Market, by Treatment Type
5.3 Top 3 Countries
5.4 Pre-Exposure Immunization
5.5 Post-exposure prophylaxis

Chapter 6 Global Human Rabies Treatment Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Human Rabies Treatment Market, by Product Type, 2015- 2025 (US$)
6.2.2 North America Human Rabies Treatment Market, by Treatment Type, 2015- 2025 (US$)
6.2.3 North America Human Rabies Treatment Market, by Country, 2015- 2025 (US$)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Human Rabies Treatment Market, by Product Type, 2015- 2025 (US$)
6.3.2 Europe Human Rabies Treatment Market, by Treatment Type, 2015- 2025 (US$)
6.3.3 Europe Human Rabies Treatment Market, by Country, 2015- 2025 (US$)
6.4 Asia Pacific (China, Japan and Rest of APAC)
6.4.1 Asia Pacific Human Rabies Treatment Market, by Product Type, 2015- 2025 (US$)
6.4.2 Asia Pacific Human Rabies Treatment Market, by Treatment Type, 2015- 2025 (US$)
6.4.1 Asia Pacific Human Rabies Treatment Market, by Country, 2015- 2025 (US$)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Human Rabies Treatment Market, by Product Type, 2015- 2025 (US$)
6.5.2 Latin America Human Rabies Treatment Market, by Treatment Type, 2015- 2025 (US$)
6.5.3 Latin America Human Rabies Treatment Market, by Country, 2015- 2025 (US$)
6.6 Middle East and Africa (GCC and Rest of MEA)
6.6.1 Middle East and Africa Human Rabies Treatment Market, by Product Type, 2015- 2025 (US$)
6.6.2 Middle East and Africa Human Rabies Treatment Market, by Treatment Type, 2015- 2025 (US$)
6.6.3 Middle East and Africa Human Rabies Treatment Market, by Country, 2015- 2025 (US$)

Chapter 7 Company Profiles
7.1 Bio Med Pvt. Ltd.
7.2 Biological E Ltd.
7.3 Cadila Healthcare
7.4 CSC Pharmaceuticals International
7.5 GlaxoSmithKline GmbH
7.6 Grifols S.A.
7.7 Kamada Ltd.
7.8 Kedrion S.p.A.
7.9 Novartis International AG
7.10 Sanofi Pasteur SA
7.11 Serum institute of India

List of Figures
Fig. 1 Human Rabies Treatment Market: Research Methodology
Fig. 2 Global Human Rabies Treatment Market, by Product Type, 2016 (US$ Bn)
Fig. 3 Global Human Rabies Treatment Market, by Treatment Type, 2016 (US$ Bn)
Fig. 4 Global Human Rabies Treatment Market Share, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition: Global Human Rabies Treatment Market, by Geography, 2016
Fig. 6 Attractive Investment Proposition: Global Human Rabies Treatment Market, by Product type, 2016
Fig. 7 Global Cell Culture Vaccines Market, 2015 - 2025 (US$ Bn)
Fig. 8 Global Rabies Immunoglobulin Market, 2015 - 2025 (US$ Bn)
Fig. 9 Global Nerve Tissue Vaccines Market, 2015 - 2025 (US$ Bn)
Fig. 10 Global Other Human Rabies Treatment Market, 2015 - 2025 (US$ Bn)
Fig. 11 Attractive Investment Proposition: Global Human Rabies Treatment Market, by Treatment Type, 2016
Fig. 12 Global Rabies Pre-Exposure Immunization Market, 2015 - 2025 (US$ Bn)
Fig. 13 Global Rabies Post-exposure prophylaxis Market, 2015 - 2025 (US$ Bn)

List of Tables
Table 1 Market Positioning of Key Players in Global Human Rabies Treatment Market
Table 2 Global Human Rabies Treatment Market, by Product Type, 2015 - 2025 (US$ Bn)
Table 3 Top 3 Countries in Global Human Rabies Treatment Market, 2015 - 2025 (US$ Bn)
Table 4 Global Human Rabies Treatment Market, by Treatment Type, 2015 - 2025 (US$ Bn)
Table 5 Top 3 Countries in Global Human Rabies Treatment Market, by Treatment Type 2015 - 2025 (US$ Bn)
Table 6 Global Human Rabies Treatment Market, by Geography, 2015 - 2025 (US$ Bn)
Table 7 North America Human Rabies Treatment Market, by Product Type, 2015-2025 (US$ Bn)
Table 8 North America Human Rabies Treatment Market, by Treatment Type, 2015-2025 (US$ Bn)
Table 9 North America Human Rabies Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 10 Europe Human Rabies Treatment Market, by Product Type, 2015-2025 (US$ Bn)
Table 11 Europe Human Rabies Treatment Market, by Treatment Type, 2015-2025 (US$ Bn)
Table 12 Europe Human Rabies Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 13 Asia Pacific Human Rabies Treatment Market, by Product Type, 2015-2025 (US$ Bn)
Table 14 Asia Pacific Human Rabies Treatment Market, by Treatment Type, 2015-2025 (US$ Bn)
Table 15 Asia Pacific Human Rabies Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 16 Latin America Human Rabies Treatment Market, by Product Type, 2015-2025 (US$ Bn)
Table 17 Latin America Human Rabies Treatment Market, by Treatment Type, 2015-2025 (US$ Bn)
Table 18 Latin America Human Rabies Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 19 Middle East and Africa Human Rabies Treatment Market, by Product Type, 2015-2025 (US$ Bn)
Table 20 Middle East and Africa Human Rabies Treatment Market, by Treatment Type, 2015-2025 (US$ Bn)
Table 21 Middle East and Africa Human Rabies Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 22 Bio Med Pvt. Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 23 Biological E Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 24 Cadila Healthcare: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 25 CSC Pharmaceuticals International: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 26 GlaxoSmithKline GmbH: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 27 Grifols S.A.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 28 Kamada Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 29 Kedrion S.p.A.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 30 Novartis International AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 31 Sanofi Pasteur SA: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 32 Serum institute of India: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bio Med Pvt. Ltd.
  • Biological E Ltd.
  • Cadila Healthcare
  • CSC Pharmaceuticals International
  • GlaxoSmithKline GmbH
  • Grifols S.A.
  • Kamada Ltd.
  • Kedrion S.p.A.
  • Novartis International AG
  • Sanofi Pasteur SA
  • Serum institute of India
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll